Tags : Gimoti

Insights+: The US FDA New Drug Approvals in June 2020

 The US FDA has approved multiple NDAs and BLAs in Jun 2020, leading to treatments for patients and advances in the health care industry. The Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 51 novel products so far in 2020, including 8 in Jun 2020. Additionally, […]Read More

Evarsana Signs an Agreement with Evoke Pharma to Commercialize Gimoti

Shots: Evoke to receive $5M revolving credit facility following FDA approval of Gimoti while Eversana will utilize its outsourced services to commercialize and distribute Gimoti in the US Evoke will remain responsible for legal, regulatory, and manufacturing activities and retain 80% of the profit and record sales for Gimoti to Eversana’s third-party logistics division. Evarsana […]Read More